Product
RoActemra
1 clinical trial
1 indication
Indication
Rheumatoid ArthritisClinical trial
A Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Two-Arm Study to Evaluate the Efficacy, Safety and Immunogenicity of MSB11456 Compared to European Union-approved RoActemra® in Patients With Moderately to Severely Active Rheumatoid Arthritis (APTURA I Study)Status: Completed, Estimated PCD: 2021-08-31